“We can’t continue to put every drug willy-nilly on every formulary,” says David B. Nash, MD, MBA, the founding dean of the Jefferson School of Population Health at Thomas Jefferson University in Philadelphia. Some organization will need to start monitoring this, but he hopes it won’t be another federal agency. 

Watch the full interview with Dr. Nash or read the edited transcript.